ストックスクリーナーアプリを入手
30.78
0.36%
-0.1097
前日終値:
$30.89
開ける：
$30.5
24時間の取引高:
60,817
Relative Volume:
0.39
時価総額：
$549.47M
収益：
$138.20M
当期純損益:
$5.52M
株価収益率:
81.00
EPS:
0.38
ネットキャッシュフロー:
$9.86M
1週間 パフォーマンス:
+0.98%
1か月 パフォーマンス:
-6.34%
6か月 パフォーマンス:
-19.79%
1年 パフォーマンス:
+14.12%
1日の値動き範囲:
$29.20
$30.99
1週間の範囲:
$29.20
$31.18
52週間の値動き範囲:
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
SRDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
30.75 | 549.47M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
131.78 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.18 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.30 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.68 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.84 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | アップグレード | Lake Street | Hold → Buy |
| 2023-06-13 | アップグレード | Needham | Hold → Buy |
| 2023-02-13 | ダウングレード | Needham | Buy → Hold |
| 2020-07-23 | アップグレード | Needham | Hold → Buy |
| 2019-12-11 | ダウングレード | Needham | Buy → Hold |
| 2019-11-01 | ダウングレード | Lake Street | Buy → Hold |
| 2019-08-01 | 繰り返されました | Needham | Buy |
| 2019-05-02 | 繰り返されました | Lake Street | Buy |
| 2019-05-02 | 繰り返されました | Needham | Buy |
| 2019-02-21 | 繰り返されました | Needham | Buy |
| 2018-05-16 | 繰り返されました | Needham | Buy |
| 2018-03-01 | アップグレード | Sidoti | Neutral → Buy |
| 2018-02-28 | 繰り返されました | Lake Street | Buy |
| 2018-02-28 | 開始されました | Needham | Buy |
| 2017-07-14 | 開始されました | Lake Street | Buy |
| 2016-11-21 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-05-03 | 繰り返されました | Barrington Research | Outperform |
| 2015-08-06 | 繰り返されました | Barrington Research | Outperform |
| 2015-03-27 | 開始されました | Dougherty & Company | Buy |
| 2014-02-25 | 開始されました | Laidlaw | Buy |
| 2013-08-01 | アップグレード | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Surmodics Inc (SRDX) 最新ニュース
Gardner Lewis Asset Management L P Raises Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Learn to Evaluate (SRDX) using the Charts - Stock Traders Daily
PE Firm Hits Back Against Medical Device Coating Challenge - Law360
FTC Challenges Medical Device Coatings Deal - Medical Product Outsourcing
Bank of New York Mellon Corp Sells 2,966 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Here's Why You Should Retain Surmodics Stock in Your Portfolio Now - Zacks Investment Research
GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the First FTC Merger Challenge Under Trump - JD Supra
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics - Yahoo Finance
Medical Coating Market Projected To Witness Substantial Growth, 2025-2032: Freudenberg Medical Europe GmbH, - EIN News
Surmodics (NASDAQ:SRDX) Stock Rating Upgraded by Lake Street Capital - Defense World
Lake Street Upgrades Surmodics (SRDX) - Nasdaq
SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge - MSN
Where are the Opportunities in (SRDX) - Stock Traders Daily
Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private - Benzinga
FTC Sues to Block Sale of Surmodics - PlasticsToday
FTC targets GTCR in agency's first merger challenge under new Trump term - Crain's Chicago Business
FTC challenges private equity firm’s acquisition of Surmodics - MassDevice
FTC challenges $627M private equity takeover of Surmodics - MedTech Dive
Surmodics remains committed to GTCR merger despite US FTC suit - MLex
Why Surmodics Stock Is Falling On Friday - Benzinga India
Surmodics says it will defend proposed acquisition by GTCR against FTC lawsuit - pehub.com
Lake Street Upgrades SurModics to Buy From Hold, Price Target is $43 -March 07, 2025 at 08:46 am EST - Marketscreener.com
Surmodics Vows to Oppose FTC Decision to Block GTCR Deal -March 07, 2025 at 04:39 am EST - Marketscreener.com
Rhumbline Advisers Boosts Stake in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Surmodics contests FTC challenge to GTCR acquisition By Investing.com - Investing.com South Africa
Surmodics Responds To FTC Challenge, Commits To Completing Merger With GTCR - Nasdaq
US FTC sues to block private equity purchase of medical company - Reuters.com
Surmodics Says Disagrees With FTC's Decision And Remains Committed To Completing Merger with GTCR - Marketscreener.com
Surmodics contests FTC challenge to GTCR acquisition - Investing.com
Will FTC Block Surmodics' $627M Deal? Company Ready for Court Battle - StockTitan
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR - Business Wire
FTC Challenges PE Firm's Medical Device Coatings Deal - Law360
US FTC sues to block GTCR-Surmodics deal - MLex
FTC sues to block GTCR’s $627M Surmodics acquisition - Modern Healthcare
US FTC sues to block private equity buy of medical company -March 06, 2025 at 04:47 pm EST - Marketscreener.com
FTC Sues GTCR, Surmodics Over Medical Device Coatings Deal (1) - Bloomberg Law
FTC sues to block private equity firm's deal to buy medical device coatings maker Surmodics - Marketscreener.com
GTCR-Surmodics merger challenged by US FTC - MLex
FTC sues to block acquisition of Surmodics - TipRanks
Surmodics drops after FTC files suit to block its planned sale to GTCR (SRDX:NASDAQ) - Seeking Alpha
Surmodics drops on report it will meet with regulators to try to save deal - MSN
Surmodics drops on report it will meet with regulators to try to save deal (SRDX:NASDAQ) - Seeking Alpha
SurModics: Fiscal Q3 Earnings Snapshot -July 31, 2024 at 07:17 am EDT - Marketscreener.com
Phocas Financial Corp. Cuts Stock Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics Reports Successful Clinical Use of its Pounce XL Thrombectomy System - MPO-mag
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by Olympiad Research LP - MarketBeat
How to Take Advantage of moves in (SRDX) - Stock Traders Daily
Zacks Research Has Bullish Outlook for Surmodics Q2 Earnings - Armenian Reporter
What is Zacks Research’s Estimate for Surmodics Q2 Earnings? - Defense World
Q3 Earnings Forecast for Surmodics Issued By Zacks Research - Defense World
Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
Surmodics Inc (SRDX) 財務データ
収益
当期純利益
現金流量
EPS
Surmodics Inc (SRDX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| DANTZKER DAVID | Director |
Feb 13 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
44,399 |
| BEDOYA JOSE H | Director |
Feb 14 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
34,232 |
| KNIGHT SUSAN E | Director |
Jan 24 '25 |
Option Exercise |
27.30 |
7,358 |
200,873 |
42,506 |
| Arens Timothy J. | Chief Financial Officer |
Nov 26 '24 |
Sale |
39.44 |
7,009 |
276,453 |
70,350 |
0.44%
0.15%
大文字化:
|
ボリューム (24 時間):